Cognitive reserve moderates the effect of COVID-19 on cognition: A systematic review and meta-analysis of individual participant data
Foreman; Child; Saywell; Collins-Praino; Baetu
Elucidating the factors that mitigate the effects of COVID-19 on cognitive function offers important insights for public health policy and intervention. This systematic review and individual participant data (IPD) meta-analysis assesses cognitive reserve (CR) as a potential moderator of post-COVID-19 cognitive dysfunction (PCCD).
Under PRISMA-IPD guidelines, data searches were conducted via PubMed, PsycINFO, Scopus, and Embase, up to January 2023. Eligible studies included at least one cognitive assessment, CR proxy, and disease severity indicator. Of 5,604 studies, 87 were eligible (10,950 COVID-19 cases; 78,305 controls), and IPD was obtained for 29 datasets (3,919 COVID-19 cases; 8,267 controls).
Three-level random-effects meta-analyses indicated that CR had a moderate positive association (rsp =.29), and COVID-19 severity had a small negative association (rsp = -.07) with cognitive outcomes. These effects were moderated by a significant within-study interaction. Cognitive deficits following COVID-19 were 33% smaller among high CR individuals, and 33% greater among low CR individuals, relative to those with average CR.
Population-based initiatives promoting reserve-building behaviors may alleviate the PCCD-related public health burden.
HIGHLIGHTS
• Cognitive reserve moderates the effect of COVID-19 severity on cognition.
• This moderation effect can be found at both the within- and between-study level.
• High cognitive reserve is a protective factor which reduces the impact of COVID-19 on cognition.
• The effect is present across the whole COVID-19 spectrum, including in mild cases.
• Population-based public health initiatives should promote reserve-building behaviors.
Link (Neuroscience & Biobehavioral Reviews)
Foreman; Child; Saywell; Collins-Praino; Baetu
Elucidating the factors that mitigate the effects of COVID-19 on cognitive function offers important insights for public health policy and intervention. This systematic review and individual participant data (IPD) meta-analysis assesses cognitive reserve (CR) as a potential moderator of post-COVID-19 cognitive dysfunction (PCCD).
Under PRISMA-IPD guidelines, data searches were conducted via PubMed, PsycINFO, Scopus, and Embase, up to January 2023. Eligible studies included at least one cognitive assessment, CR proxy, and disease severity indicator. Of 5,604 studies, 87 were eligible (10,950 COVID-19 cases; 78,305 controls), and IPD was obtained for 29 datasets (3,919 COVID-19 cases; 8,267 controls).
Three-level random-effects meta-analyses indicated that CR had a moderate positive association (rsp =.29), and COVID-19 severity had a small negative association (rsp = -.07) with cognitive outcomes. These effects were moderated by a significant within-study interaction. Cognitive deficits following COVID-19 were 33% smaller among high CR individuals, and 33% greater among low CR individuals, relative to those with average CR.
Population-based initiatives promoting reserve-building behaviors may alleviate the PCCD-related public health burden.
HIGHLIGHTS
• Cognitive reserve moderates the effect of COVID-19 severity on cognition.
• This moderation effect can be found at both the within- and between-study level.
• High cognitive reserve is a protective factor which reduces the impact of COVID-19 on cognition.
• The effect is present across the whole COVID-19 spectrum, including in mild cases.
• Population-based public health initiatives should promote reserve-building behaviors.
Link (Neuroscience & Biobehavioral Reviews)